Header cover image

Hong Kong (HSI) Healthcare Sector Analysis

UpdatedDec 14, 2024
DataAggregated Company Financials
Companies198
  • 7D0.2%
  • 3M7.0%
  • 1Y-15.1%
  • YTD-13.7%

The Healthcare industry is up 3.1% in the last week, with Sinopharm Group up 6.8%. In the same time, XtalPi Holdings was down 21%. However, the industry is down 13% over the past year. Looking forward, earnings are forecast to grow by 28% annually.

Sector Valuation and Performance

Has the Hong Kong Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 14 Dec 2024HK$1.4tHK$1.4tHK$29.2b12.2x47x1x
Mon, 11 Nov 2024HK$1.4tHK$1.4tHK$29.2b12.6x47.4x1x
Wed, 09 Oct 2024HK$1.5tHK$1.5tHK$30.6b13x50x1x
Fri, 06 Sep 2024HK$1.3tHK$1.5tHK$29.5b11.3x42.8x0.9x
Sun, 04 Aug 2024HK$1.2tHK$1.4tHK$27.9b10.5x43.3x0.8x
Tue, 02 Jul 2024HK$1.2tHK$1.4tHK$28.6b10.8x43.6x0.9x
Thu, 30 May 2024HK$1.3tHK$1.4tHK$28.6b12.2x45x0.9x
Sat, 27 Apr 2024HK$1.3tHK$1.4tHK$28.7b11.6x46.9x0.9x
Mon, 25 Mar 2024HK$1.3tHK$1.4tHK$28.1b11.6x47x0.9x
Wed, 21 Feb 2024HK$1.3tHK$1.4tHK$27.1b11.5x48.4x0.9x
Fri, 19 Jan 2024HK$1.4tHK$1.4tHK$25.9b11.6x54.5x1x
Sun, 17 Dec 2023HK$1.6tHK$1.4tHK$26.5b13.1x59.2x1.1x
Tue, 14 Nov 2023HK$1.6tHK$1.4tHK$25.0b12.8x65.7x1.2x
Thu, 12 Oct 2023HK$1.6tHK$1.4tHK$24.6b12.2x64.9x1.1x
Sat, 09 Sep 2023HK$1.6tHK$1.4tHK$25.1b12.4x61.9x1.1x
Mon, 07 Aug 2023HK$1.7tHK$1.3tHK$14.1b14.8x118.4x1.2x
Wed, 05 Jul 2023HK$1.7tHK$1.4tHK$2.5b13.9x695.4x1.3x
Fri, 02 Jun 2023HK$1.7tHK$1.3tHK$3.2b13.9x537.8x1.3x
Sun, 30 Apr 2023HK$1.9tHK$1.4tHK$4.6b16.4x417.3x1.4x
Tue, 28 Mar 2023HK$1.9tHK$1.4tHK$410.2m15.5x4553.2x1.4x
Thu, 23 Feb 2023HK$2.0tHK$1.3tHK$2.0b15.8x977.1x1.4x
Sat, 21 Jan 2023HK$2.1tHK$1.4tHK$2.2b15.8x935x1.5x
Mon, 19 Dec 2022HK$1.9tHK$1.3tHK$2.1b14.2x875.3x1.4x
Wed, 16 Nov 2022HK$1.8tHK$1.3tHK$1.1b13.6x1731.7x1.4x
Fri, 14 Oct 2022HK$1.4tHK$1.3tHK$2.6b12.7x554.1x1.1x
Sun, 11 Sep 2022HK$1.7tHK$1.3tHK$3.2b14.3x535.4x1.3x
Tue, 09 Aug 2022HK$1.8tHK$1.3t-HK$966,498,139.0013.6x-1878.2x1.4x
Thu, 07 Jul 2022HK$2.0tHK$1.3t-HK$1,057,073,541.0015.1x-1897.1x1.5x
Sat, 04 Jun 2022HK$1.6tHK$1.3t-HK$2,376,937,222.0013.2x-685.2x1.2x
Mon, 02 May 2022HK$1.7tHK$1.3t-HK$2,054,351,924.0014x-808.3x1.3x
Wed, 30 Mar 2022HK$1.8tHK$1.3tHK$6.3b14x283x1.3x
Fri, 25 Feb 2022HK$1.9tHK$1.3tHK$8.7b13.8x223.2x1.4x
Sun, 23 Jan 2022HK$2.3tHK$1.3tHK$7.9b15.6x285.9x1.7x
Tue, 21 Dec 2021HK$2.2tHK$1.3tHK$8.0b13.9x279.6x1.7x
Price to Earnings Ratio

279.6x


Total Market Cap: HK$2.2tTotal Earnings: HK$8.0bTotal Revenue: HK$1.3tTotal Market Cap vs Earnings and Revenue0%0%0%
Hong Kong Healthcare Sector Price to Earnings3Y Average 123.5x202220232024
Current Industry PE
  • Investors are pessimistic on the Hong Kong Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 47.8x which is lower than its 3-year average PE of 124x.
  • The 3-year average PS ratio of 1.2x is higher than the industry's current PS ratio of 0.98x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 54% per year over the last three years.
  • Revenues for these companies have grown 2.2% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Hong Kong Healthcare sector?

HK Market0.35%
Healthcare0.23%
Healthtech5.15%
Medical Equipment3.40%
Healthcare Services2.88%
Life Sciences-0.53%
Pharma-0.81%
Biotech-1.02%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry which is trading above its 3-year average PE ratio.
    • Analysts are expecting annual earnings growth of 40.2%, which is higher than its past year's earnings decline of 4.3% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 43% over the next 5 years.
  • This is better than its past earnings growth rate of 14% per year.
  • In contrast, the Pharma industry is expected to see its earnings grow by 11% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
1099 Sinopharm GroupHK$21.956.8%
+HK$4.4b
14.3%PE7.4x
2268 WuXi XDC CaymanHK$31.208.5%
+HK$2.9b
3.0%PE58.8x
2252 Shanghai MicroPort MedBot (Group)HK$11.1034.1%
+HK$2.7b
-42.7%PS64.6x
2522 Jiangxi Rimag GroupHK$58.9513.9%
+HK$2.6b
n/aPE3727.8x
2269 WuXi Biologics (Cayman)HK$17.802.7%
+HK$1.9b
-39.7%PE26x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

2252

HK$11.10

Shanghai MicroPort MedBot (Group)

7D

34.1%

1Y

-42.7%

2522

HK$58.95

Jiangxi Rimag Group

7D

13.9%

1Y

n/a

2162

HK$37.90

Keymed Biosciences

7D

-7.1%

1Y

-26.8%

2268

HK$31.20

WuXi XDC Cayman

7D

8.5%

1Y

3.0%

1093

HK$4.80

CSPC Pharmaceutical Group

7D

-4.0%

1Y

-31.9%

9926

HK$63.65

Akeso

7D

-2.4%

1Y

37.8%

2105

HK$11.88

Laekna

7D

-17.7%

1Y

-36.3%

2269

HK$17.80

WuXi Biologics (Cayman)

7D

2.7%

1Y

-39.7%

1548

HK$10.10

Genscript Biotech

7D

-10.1%

1Y

-51.9%

9969

HK$6.17

InnoCare Pharma

7D

-7.2%

1Y

-3.4%